232 related articles for article (PubMed ID: 8347952)
1. Renal cancer staging: comparison of contrast-enhanced CT and gadolinium-enhanced fat-suppressed spin-echo and gradient-echo MR imaging.
Semelka RC; Shoenut JP; Magro CM; Kroeker MA; MacMahon R; Greenberg HM
J Magn Reson Imaging; 1993; 3(4):597-602. PubMed ID: 8347952
[TBL] [Abstract][Full Text] [Related]
2. Detection of pseudocapsule of renal cell carcinoma with MR imaging and CT.
Yamashita Y; Honda S; Nishiharu T; Urata J; Takahashi M
AJR Am J Roentgenol; 1996 May; 166(5):1151-5. PubMed ID: 8615260
[TBL] [Abstract][Full Text] [Related]
3. Combined gadolinium-enhanced and fat-saturation MR imaging of renal masses.
Semelka RC; Hricak H; Stevens SK; Finegold R; Tomei E; Carroll PR
Radiology; 1991 Mar; 178(3):803-9. PubMed ID: 1994422
[TBL] [Abstract][Full Text] [Related]
4. Renal lesions: controlled comparison between CT and 1.5-T MR imaging with nonenhanced and gadolinium-enhanced fat-suppressed spin-echo and breath-hold FLASH techniques.
Semelka RC; Shoenut JP; Kroeker MA; MacMahon RG; Greenberg HM
Radiology; 1992 Feb; 182(2):425-30. PubMed ID: 1732961
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of renal masses with contrast-enhanced rapid acquisition spin echo MR imaging.
Eilenberg SS; Brown JJ; Lee JK; Heiken JP; Mirowitz SA
Magn Reson Imaging; 1993; 11(1):7-16. PubMed ID: 8423725
[TBL] [Abstract][Full Text] [Related]
6. Primary ovarian cancer: prospective comparison of contrast-enhanced CT and pre-and postcontrast, fat-suppressed MR imaging, with histologic correlation.
Semelka RC; Lawrence PH; Shoenut JP; Heywood M; Kroeker MA; Lotocki R
J Magn Reson Imaging; 1993; 3(1):99-106. PubMed ID: 8428108
[TBL] [Abstract][Full Text] [Related]
7. Bowel disease: prospective comparison of CT and 1.5-T pre- and postcontrast MR imaging with T1-weighted fat-suppressed and breath-hold FLASH sequences.
Semelka RC; Shoenut JP; Silverman R; Kroeker MA; Yaffe CS; Micflikier AB
J Magn Reson Imaging; 1991; 1(6):625-32. PubMed ID: 1823167
[TBL] [Abstract][Full Text] [Related]
8. Bladder tumor staging: comparison of contrast-enhanced CT, T1- and T2-weighted MR imaging, dynamic gadolinium-enhanced imaging, and late gadolinium-enhanced imaging.
Kim B; Semelka RC; Ascher SM; Chalpin DB; Carroll PR; Hricak H
Radiology; 1994 Oct; 193(1):239-45. PubMed ID: 8090898
[TBL] [Abstract][Full Text] [Related]
9. MR imaging of the gastrointestinal tract with i.v., gadolinium and diluted barium oral contrast media compared with unenhanced MR imaging and CT.
Low RN; Francis IR
AJR Am J Roentgenol; 1997 Oct; 169(4):1051-9. PubMed ID: 9308464
[TBL] [Abstract][Full Text] [Related]
10. [Role of gadolinium (Gd-DTPA) in the staging of renal carcinoma using magnetic resonance. Comparative evaluation with computerized tomography and magnetic resonance without contrast media].
De Cobelli F; Vanzulli A; Colombo E; Bonato C; Sironi S; Del Maschio A
Radiol Med; 1993 May; 85(5):562-9. PubMed ID: 8327756
[TBL] [Abstract][Full Text] [Related]
11. MR imaging evaluation of renal cell carcinoma.
Narumi Y; Hricak H; Presti JC; Forstner R; Sica GT; Kuroda C; Sawai Y; Kotake T; Kinouchi T; Carroll PR
Abdom Imaging; 1997; 22(2):216-25. PubMed ID: 9013538
[TBL] [Abstract][Full Text] [Related]
12. Peritoneal tumor: MR imaging with dilute oral barium and intravenous gadolinium-containing contrast agents compared with unenhanced MR imaging and CT.
Low RN; Barone RM; Lacey C; Sigeti JS; Alzate GD; Sebrechts CP
Radiology; 1997 Aug; 204(2):513-20. PubMed ID: 9240546
[TBL] [Abstract][Full Text] [Related]
13. Islet cell tumors: comparison of dynamic contrast-enhanced CT and MR imaging with dynamic gadolinium enhancement and fat suppression.
Semelka RC; Cumming MJ; Shoenut JP; Magro CM; Yaffe CS; Kroeker MA; Greenberg HM
Radiology; 1993 Mar; 186(3):799-802. PubMed ID: 8381551
[TBL] [Abstract][Full Text] [Related]
14. Gadolinium-enhanced MR imaging of renal masses.
Rominger MB; Kenney PJ; Morgan DE; Bernreuter WK; Listinsky JJ
Radiographics; 1992 Nov; 12(6):1097-116; discussion 1117-8. PubMed ID: 1439014
[TBL] [Abstract][Full Text] [Related]
15. [The staging of renal-cell carcinomas in MRT and CT--a prospective histologically controlled study].
Hallscheidt P; Stolte E; Roeren T; Pomer S; Drehmer I; Kauffmann GW
Rofo; 1998 Feb; 168(2):165-70. PubMed ID: 9519049
[TBL] [Abstract][Full Text] [Related]
16. MR imaging of head and neck tumors: comparison of T1-weighted contrast-enhanced fat-suppressed images with conventional T2-weighted and fast spin-echo T2-weighted images.
Ross MR; Schomer DF; Chappell P; Enzmann DR
AJR Am J Roentgenol; 1994 Jul; 163(1):173-8. PubMed ID: 8010208
[TBL] [Abstract][Full Text] [Related]
17. Dynamic MRI of small renal cell carcinoma.
Yamashita Y; Miyazaki T; Hatanaka Y; Takahashi M
J Comput Assist Tomogr; 1995; 19(5):759-65. PubMed ID: 7560322
[TBL] [Abstract][Full Text] [Related]
18. MR imaging of peritoneal disease: comparison of contrast-enhanced fast multiplanar spoiled gradient-recalled and spin-echo imaging.
Low RN; Sigeti JS
AJR Am J Roentgenol; 1994 Nov; 163(5):1131-40. PubMed ID: 7976889
[TBL] [Abstract][Full Text] [Related]
19. Pancreatic disease: prospective comparison of CT, ERCP, and 1.5-T MR imaging with dynamic gadolinium enhancement and fat suppression.
Semelka RC; Kroeker MA; Shoenut JP; Kroeker R; Yaffe CS; Micflikier AB
Radiology; 1991 Dec; 181(3):785-91. PubMed ID: 1947098
[TBL] [Abstract][Full Text] [Related]
20. Accuracy of staging rectal tumors with contrast-enhanced transrectal MR imaging.
Vogl TJ; Pegios W; Mack MG; Hünerbein M; Hintze R; Adler A; Lobbeck H; Hammerstingl R; Wust P; Schlag P; Felix R
AJR Am J Roentgenol; 1997 Jun; 168(6):1427-34. PubMed ID: 9168702
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
